跳至主要内容
临床试验/NCT05846139
NCT05846139已完成不适用

The Effectiveness of an Incremental Approach to Nonsurgical Periodontal Therapy With the Use of Adjunctive Slow-release Locally Administered 0.02% Hypochlorite Formulation: A Single-blind Randomized Clinical Study

Tuscan Dental Institute1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年1月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
change in full mouth bleeding score (ΔFMBS)

研究概览

简要总结

Aim: The presence of bacterial plaque is associated with the development of periodontal inflammation. The aim of this single-blind randomized clinical study was to prospectively evaluate the efficacy of two different agents in a staged approach for nonsurgical periodontal treatment in terms of clinical and patients related outcomes in a cohort of patients with periodontitis: NitrAdine® based disinfectant formula (PerioTabs®) vs Chlorhexidine 0.12 toothpaste and mouthwash 0.20.

Material and methods: Patients with a diagnosis of periodontal disease (stage I-III) scheduled for non surgical periodontal treatment were randomly allocated to the preparatory home use of a chlorhexidine mouthwash or a NitrAdine® based brushing solution called PerioTabs® for 10-15 days. Active decontamination with ultrasonic scalers was performed after the completion of the preparation period. Clinical and patient-related outcomes were recorded at baseline, at the moment of professional intervention, and after 30 and 90 days from baseline.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •older than 18 y.o,
  • •systemically healthy,
  • •with a clinical diagnosis of periodontitis

排除标准

  • •alcohol or drug abuse,
  • •regular drug use of bisphosphonates,
  • •non-steroidal or steroidal anti-inflammatory,
  • •daily antacid therapy,
  • •selective serotonin reuptake inhibitors and other therapy that might affect periodontal health,
  • •antibiotics during the previous 6 months,
  • •smoking more than ten cigarettes per day;
  • •pregnancy;
  • •lactation;
  • •previous periodontitis treatment within the last 6 months,
  • •radiotherapy to the head or neck, current chemotherapy.

研究组 & 干预措施

PerioTabs® brushing solution

Experimental

At baseline, patients were given instructions for the home use of PerioTabs® for daily gum and toothbrushing for 10 consecutive days, according to the product's directions for use. The procedure consisted of brushing the teeth and gums for 2 minutes in the evening during a 10-day period. After one week, one-stage full-mouth disinfection was performed with the use of ultrasonic devices on each quadrant. In addition, two cycles of 90 seconds ozone-therapy were carried out.

干预措施: PerioTabs® brushing solution (Combination Product)

Chlorhexidine 0.2% mouth rinse

Active Comparator

At baseline, patients were given instructions for the home use of toothbrush with chlorhexidine 0.12 % toothpaste for 15 days toothbrushing twice daily (morning and evening). Also, a chlorhexidine 0.2% mouth rinse had to be used every evening for the course of the 15 days. After two weeks, the one-stage full-mouth disinfection was performed in the same way as in Group 1.

干预措施: Chlorhexidine 0.12 % (Combination Product)

结局指标

主要结局

change in full mouth bleeding score (ΔFMBS)

时间窗: Between baseline and the active debridement which occurred 15 days later

次要结局

未报告次要终点

研究者

发起方
Tuscan Dental Institute
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验